Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction. Packer M, Cleland JGF, Bauersachs J. Eur Heart J 2024 May 28:ehae300. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Packer M, Cleland JGF, Bauersachs J. Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction. Eur Heart J 2024 May 28:ehae300. doi: 10.1093.
PMID: 38805680